Originally Presented at IDWeek October 2022
Real-world data and patient case studies utilizing the CMV inSIGHT™ T Cell Immunity
test. Identify how you can utilize this cell mediated immunity assay in your immunocompromised patients to evaluate their immune response to CMV. These answers can assist in personalizing your approach to your patients CMV antiviral therapy.
Length of Presentation: 56 minutes
